TaslyUS Ransomware Attack
Ransomware victimRansomed
About this victim
Tasly Pharmaceuticals, Inc. (Tasly U.S.) is “Dedicated to a Healthier World.” And our vision is that the world will change the way it takes and understands medicine. Founded in 2006, and following years of research and development, Tasly U.S., based in Rockville, Maryland, is positioned to become a world-renowned innovator in pharmaceuticals, biologics, and nutraceuticals. Among our key accomplishments to date: T89 (Dantonic) has become the first herbal medicine-derived compound to complete an FDA Phase III global trial, yielding promising data. Results indicate that T89’s pharmacological functionalities express clinically significant benefits, including improving blood circulation, boosting energy metabolism level, and reducing blood viscosity. Tasly U.S. believes our initial success with T89 will pave the way for the broader use of herbal medication as an effective and safe alternative to synthesized chemical and biological treatments.
Overview
View group profileIndustry
Healthcare
Country
United States
Discovered
over 3 years ago
Attack date
May 18, 2023
Confidence
70%
Severity
Medium
Status
Claimed
Threat group
alphvTotal victims
0
Victim's position within group
Industry
Healthcare
Not a listed target sector
Country
United States
Not a listed target country
Other victims
Same group (alphv) in this period
No other victims in the selected period.
View group profile